VivoSeq
Other

Vitamin D

1

Pipeline Programs

7

Active Trials

4

Companies Involved

Vitamin D is an early-stage landscape with 1 program across 4 companies. The most active players are Hyundai Pharmaceutical Co., LTD., Novartis, GSK. 1 therapy is approved.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

87/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

134

clinical trials

Completed93 · 69%
Unknown status20 · 15%
Terminated12 · 9%
Active, not recruiting3 · 2%
Not yet recruiting2 · 1%
Recruiting2 · 1%
Other2 · 1%

Trial Activity

134 trials

VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)
Active, not recruiting··N/A·NCT04573946·25,871 enrolled
Vitamin D and Omega-3 Trial (VITAL)
Active, not recruiting··Phase 3·NCT01169259·25,871 enrolled
Regime for Vitamin D Maintenance in Post-Operative Patients
Not yet recruiting··Phase 3·NCT06708741·100 enrolled
Cord Blood Plus Vitamin D and Omega 3s in T1D
Completed·UUniversity of Florida·Phase 1·NCT00873925·15 enrolled
Effects Vitamin D Suppletion on Postprandial Leukocyte Activation
Completed··N/A·NCT01967459·24 enrolled
Study of Vitamin D Supplementation on Improvement of Gums Health
Completed··N/A·NCT01422122·115 enrolled
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
Completed··Phase 4·NCT00528788·24 enrolled
Page 1 of 9

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)